Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignant disease

摘要: Peritoneal Malignant Disease (PMD) is the presence of tumoral tissue on peritoneal surface from primary tumors or other locations (e.g. digestive gynecologic). It a regional disease with poor prognosis when treated repeated “debulking” and traditional systemic chemotherapy. Cytoreduction plus hyperthermic intraperitoneal chemotherapy (HIPEC) combined multimodal procedure aimed at reducing macroscopic mass as much possible treating microscopic that out scope surgeon. This treatment may change natural history PMD, it translated into higher overall survival cancer-free offers option cure in selected cases. The high-complexity also associated complications mortality, but similar rates major oncologic procedures.